OMBLASTYS (131 I-OMBURTAMAB-YCWD)
LIVE

Serial Number

79358602

Owner

Y-mAbs Therapeutics, Inc

Attorney

Andrew N. Spivak

Filing Date

Oct 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OMBLASTYS (131 I-OMBURTAMAB-YCWD) Trademark

Serial Number: 79358602 • Registration: 7341739

OMBLASTYS (131 I-OMBURTAMAB-YCWD) is a trademark filed by Y-mAbs Therapeutics, Inc on October 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Y-mAbs Therapeutics, Inc (19 trademarks)

230 Park Avenue, Suite 3350

Entity Type: 03

Trademark Details

Filing Date

October 17, 2022

Registration Date

April 2, 2024

Published for Opposition

January 16, 2024

Goods & Services

Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; all of the aforesaid containing monoclonal antibodies

Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antibodies; industrial analysis and research services in the field of chemistry, namely antibodies

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 9, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 17, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 17, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Jan 13, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 27, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 27, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 8, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2023 TROA
REFUSAL PROCESSED BY IB
Sep 18, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 31, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 31, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 11, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 10, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 3, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 28, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 23, 2022 REPR